135 related articles for article (PubMed ID: 1481629)
1. CSF and serum ganglioside antibody patterns in MS.
Stevens A; Weller M; Wiethölter H
Acta Neurol Scand; 1992 Nov; 86(5):485-9. PubMed ID: 1481629
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.
Matà S; Lolli F; Söderström M; Pinto F; Link H
Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693
[TBL] [Abstract][Full Text] [Related]
3. A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.
Stevens A; Weller M; Wiethölter H
J Neurol Neurosurg Psychiatry; 1993 Apr; 56(4):361-4. PubMed ID: 7683329
[TBL] [Abstract][Full Text] [Related]
4. Are CSF or serum ganglioside antibodies related to peripheral nerve demyelination in neuroborreliosis, Guillain-Barré syndrome, or chronic inflammatory demyelinating polyradiculoneuropathy?
Weller M; Stevens A; Sommer N; Wiethölter H
Eur Arch Psychiatry Clin Neurosci; 1992; 242(2-3):122-6. PubMed ID: 1486101
[TBL] [Abstract][Full Text] [Related]
5. Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis.
Acarín N; Río J; Fernández AL; Tintoré M; Durán I; Galán I; Montalban X
Acta Neurol Scand; 1996; 93(2-3):99-103. PubMed ID: 8741126
[TBL] [Abstract][Full Text] [Related]
6. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.
Chiba A; Kusunoki S; Shimizu T; Kanazawa I
Ann Neurol; 1992 Jun; 31(6):677-9. PubMed ID: 1514781
[TBL] [Abstract][Full Text] [Related]
7. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.
Kasai N; Pachner AR; Yu RK
J Neurol Sci; 1986 Aug; 75(1):33-42. PubMed ID: 2427659
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulins within the central nervous system in primary Sjögren's syndrome.
Vrethem M; Ernerudh J; Lindström F; Skogh T
J Neurol Sci; 1990 Dec; 100(1-2):186-92. PubMed ID: 1708408
[TBL] [Abstract][Full Text] [Related]
9. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
10. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
11. Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barré syndrome.
Matà S; Galli E; Amantini A; Pinto F; Sorbi S; Lolli F
Eur J Neurol; 2006 Feb; 13(2):153-60. PubMed ID: 16490046
[TBL] [Abstract][Full Text] [Related]
12. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.
Koga M; Takahashi M; Yokoyama K; Kanda T
J Neurol; 2015 Aug; 262(8):1954-60. PubMed ID: 26050638
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
14. Serum IgG and IgM ganglioside GM1 antibodies in patients with multiple sclerosis.
Zaprianova E; Majtényi K; Deleva D; Mikova O; Filchev A; Sultanov B; Kolyovska V; Sultanov E; Christova L; Kmetska X; Georgiev D
Ideggyogy Sz; 2004 Mar; 57(3-4):94-9. PubMed ID: 15133910
[TBL] [Abstract][Full Text] [Related]
15. Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases.
Celet B; Akman-Demir G; Serdaroğlu P; Yentür SP; Taşci B; van Noort JM; Eraksoy M; Saruhan-Direskeneli G
J Neurol; 2000 Dec; 247(12):935-9. PubMed ID: 11200685
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid antibodies directed against neuron-associated gangliosides in HIV-1 infection.
Gisslén M; Lekman A; Fredman P
Infection; 2000; 28(3):143-8. PubMed ID: 10879637
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside antibodies: a lack of diagnostic specificity and clinical utility?
Weller M; Stevens A; Sommer N; Dichgans J; Kappler B; Wiethölter H
J Neurol; 1992 Oct; 239(8):455-9. PubMed ID: 1447574
[TBL] [Abstract][Full Text] [Related]
18. [Anti-GFAP antibodies in the cerebrospinal fluid of patients with multiple sclerosis and other neurologic diseases].
Górny M; Losy J; Wender M
Neurol Neurochir Pol; 1990; 24(1-2):17-22. PubMed ID: 2132049
[TBL] [Abstract][Full Text] [Related]
19. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
20. Antiganglioside antibodies in patients with neuropsychiatric systemic lupus erythematosus.
Pereira RM; Yoshinari NH; De Oliveira RM; Cossermelli W
Lupus; 1992 May; 1(3):175-9. PubMed ID: 1301978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
